Tobacco Control 2008;17:177-182
RESEARCH PAPERS
A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand
1 Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand
2 Department of Health Policy, Management, and Evaluation, University of Toronto, Ontario, Canada
3 Setting Priority Using Information on Cost-effectiveness Analysis, Ministry of Public Health, Thailand
4 School of Population Health, University of Queensland, Australia
Dr Nathorn Chaiyakunapruk, Department of Pharmacy Practice, Naresuan University, Phitsanulok 65000, Thailand; nui{at}u.washington.edu
Objective: To estimate the incremental cost-effectiveness ratio of a structured community pharmacist-based smoking cessation programme compared with usual care.
Design: A cost-effectiveness study using a healthcare system perspective
Population: Two simulated cohorts of smokers: male and female aged 40, 50 and 60 years who regularly smoke 10–20 cigarettes per day.
Intervention and comparator: A structured community pharmacist-based smoking cessation (CPSC) programme compared to usual care.
Main outcome measure: Cost per life year gained (LYG) attributable to the smoking cessation programme.
Results: The CPSC programme results in cost savings of 17 503.53 baht (£250; 
325; $500) to the health system and life year gains of 0.18 years for men and; costs savings of 21 499.75 baht (£307; 399; $614) and life year gains of 0.24 years for women. A series of sensitivity analyses demonstrate that both cost savings and life year gains are sensitive to variations in the discount rate and the long-term smoking quit rate associated with the intervention.
Conclusion: From the perspective of the health system, the CPSC programme yields cost savings and life year gains. This finding provides important information for health policy decision-makers when determining the magnitude of resources to be allocated to smoking cessation service in community pharmacy.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
tc.2007.022368v1
17/3/177 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
